These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Baicalein Inhibits Staphylococcus aureus Biofilm Formation and the Quorum Sensing System In Vitro. Chen Y; Liu T; Wang K; Hou C; Cai S; Huang Y; Du Z; Huang H; Kong J; Chen Y PLoS One; 2016; 11(4):e0153468. PubMed ID: 27128436 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms. Bakkiyaraj D; Pandian SK Biofouling; 2010 Aug; 26(6):711-7. PubMed ID: 20706890 [TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis of silver nanoparticles treated Staphylococcus aureus reveals potential targets for biofilm inhibition. Singh N; Rajwade J; Paknikar KM Colloids Surf B Biointerfaces; 2019 Mar; 175():487-497. PubMed ID: 30572157 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial, anti-adhesive and anti-biofilm potential of biosurfactants isolated from Pediococcus acidilactici and Lactobacillus plantarum against Staphylococcus aureus CMCC26003. Yan X; Gu S; Cui X; Shi Y; Wen S; Chen H; Ge J Microb Pathog; 2019 Feb; 127():12-20. PubMed ID: 30496836 [TBL] [Abstract][Full Text] [Related]
6. Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy? Otto M FEMS Microbiol Lett; 2004 Dec; 241(2):135-41. PubMed ID: 15598524 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Balaban N; Cirioni O; Giacometti A; Ghiselli R; Braunstein JB; Silvestri C; Mocchegiani F; Saba V; Scalise G Antimicrob Agents Chemother; 2007 Jun; 51(6):2226-9. PubMed ID: 17371825 [TBL] [Abstract][Full Text] [Related]
8. Extracellular protease in Actinomycetes culture supernatants inhibits and detaches Staphylococcus aureus biofilm formation. Park JH; Lee JH; Kim CJ; Lee JC; Cho MH; Lee J Biotechnol Lett; 2012 Apr; 34(4):655-61. PubMed ID: 22160331 [TBL] [Abstract][Full Text] [Related]
9. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467 [TBL] [Abstract][Full Text] [Related]
11. Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus. Dawgul M; Baranska-Rybak W; Kamysz E; Karafova A; Nowicki R; Kamysz W Future Med Chem; 2012 Aug; 4(12):1541-51. PubMed ID: 22917244 [TBL] [Abstract][Full Text] [Related]
12. The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response. Paharik AE; Horswill AR Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227309 [TBL] [Abstract][Full Text] [Related]
13. Use of quorum sensing inhibitors to interfere with biofilm formation and development in Burkholderia multivorans and Burkholderia cenocepacia. Brackman G; Hillaert U; Van Calenbergh S; Nelis HJ; Coenye T Res Microbiol; 2009 Mar; 160(2):144-51. PubMed ID: 19146953 [TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of Staphylococcus aureus biofilms. Bhattacharya M; Wozniak DJ; Stoodley P; Hall-Stoodley L Expert Rev Anti Infect Ther; 2015; 13(12):1499-516. PubMed ID: 26646248 [TBL] [Abstract][Full Text] [Related]
15. Impact of Environmental Cues on Staphylococcal Quorum Sensing and Biofilm Development. Kavanaugh JS; Horswill AR J Biol Chem; 2016 Jun; 291(24):12556-12564. PubMed ID: 27129223 [TBL] [Abstract][Full Text] [Related]
16. Role of BP*C@AgNPs in Bap-dependent multicellular behavior of clinically important methicillin-resistant Staphylococcus aureus (MRSA) biofilm adherence: A key virulence study. Zhang X; Manukumar HM; Rakesh KP; Karthik CS; Nagendra Prasad HS; Swamy SN; Mallu P; Eissa Mohammed YH; Qin HL Microb Pathog; 2018 Oct; 123():275-284. PubMed ID: 30041001 [TBL] [Abstract][Full Text] [Related]
17. Effect of biologically synthesised silver nanoparticles on Staphylococcus aureus biofilm quenching and prevention of biofilm formation. Masurkar SA; Chaudhari PR; Shidore VB; Kamble SP IET Nanobiotechnol; 2012 Sep; 6(3):110-4. PubMed ID: 22894535 [TBL] [Abstract][Full Text] [Related]
18. Combination of Silver Nanoparticles and Curcumin Nanoparticles for Enhanced Anti-biofilm Activities. Loo CY; Rohanizadeh R; Young PM; Traini D; Cavaliere R; Whitchurch CB; Lee WH J Agric Food Chem; 2016 Mar; 64(12):2513-22. PubMed ID: 26595817 [TBL] [Abstract][Full Text] [Related]
19. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains. Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624 [TBL] [Abstract][Full Text] [Related]
20. Novel therapeutic strategies to counter Pseudomonas aeruginosa infections. Fothergill JL; Winstanley C; James CE Expert Rev Anti Infect Ther; 2012 Feb; 10(2):219-35. PubMed ID: 22339195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]